Trial Profile
A phase Ib clinical trial of Non-Hodgkin's-lymphoma-vaccine in patients with non-Hodgkin's follicular lymphoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Apr 2017
Price :
$35
*
At a glance
- Drugs Non Hodgkin's lymphoma vaccine XEME Biopharma (Primary)
- Indications Follicular lymphoma; Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 21 Apr 2017 Results published in the Blood
- 21 Apr 2017 Results published in the XEME Biopharma Inc company website. (http://www.xemebiopharma.com/experimental-and-clinical-evidence).
- 21 Apr 2017 New trial record